These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 19948162)
1. Long-chain polyunsaturated fatty acid status in phenylketonuric patients treated with tetrahydrobiopterin. Vilaseca MA; Lambruschini N; Gómez-López L; Gutiérrez A; Moreno J; Tondo M; Artuch R; Campistol J Clin Biochem; 2010 Mar; 43(4-5):411-5. PubMed ID: 19948162 [TBL] [Abstract][Full Text] [Related]
2. Long-chain polyunsaturated fatty acid concentration in patients with inborn errors of metabolism. Vilaseca MA; Gómez-López L; Lambruschini N; Gutiérrez A; García R; Meavilla S; Moreno J; Artuch R Nutr Hosp; 2011; 26(1):128-36. PubMed ID: 21519739 [TBL] [Abstract][Full Text] [Related]
3. Essential polyunsaturated fatty acids in plasma and erythrocytes of children with inborn errors of amino acid metabolism. Vlaardingerbroek H; Hornstra G; de Koning TJ; Smeitink JA; Bakker HD; de Klerk HB; Rubio-Gozalbo ME Mol Genet Metab; 2006 Jun; 88(2):159-65. PubMed ID: 16530443 [TBL] [Abstract][Full Text] [Related]
4. Biochemical effects of supplemented long-chain polyunsaturated fatty acids in hyperphenylalaninemia. Agostoni C; Scaglioni S; Bonvissuto M; Bruzzese MG; Giovannini M; Riva E Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):111-5. PubMed ID: 11237478 [TBL] [Abstract][Full Text] [Related]
5. Essential and long-chain polyunsaturated fatty acid status and fatty acid composition of breast milk of lactating adolescents. Meneses F; Torres AG; Trugo NM Br J Nutr; 2008 Nov; 100(5):1029-37. PubMed ID: 18307833 [TBL] [Abstract][Full Text] [Related]
6. Lower n-3 long-chain polyunsaturated fatty acid values in patients with phenylketonuria: a systematic review and meta-analysis. Lohner S; Fekete K; Decsi T Nutr Res; 2013 Jul; 33(7):513-20. PubMed ID: 23827125 [TBL] [Abstract][Full Text] [Related]
7. A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria. Agostoni C; Harvie A; McCulloch DL; Demellweek C; Cockburn F; Giovannini M; Murray G; Harkness RA; Riva E Dev Med Child Neurol; 2006 Mar; 48(3):207-12. PubMed ID: 16483397 [TBL] [Abstract][Full Text] [Related]
8. Long-chain polyunsaturated fatty acids profile in plasma phospholipids of hyperphenylalaninemic children on unrestricted diet. Giovannini M; Verduci E; Radaelli G; Lammardo A; Minghetti D; Cagnoli G; Salvatici E; Riva E Prostaglandins Leukot Essent Fatty Acids; 2011; 84(1-2):39-42. PubMed ID: 20888208 [TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid in red blood cells of term infants receiving two levels of long-chain polyunsaturated fatty acids. Hoffman DR; Wheaton DK; James KJ; Tuazon M; Diersen-Schade DA; Harris CL; Stolz S; Berseth CL J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):287-92. PubMed ID: 16540798 [TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trial of essential fatty acid supplementation in phenylketonuria. Cleary MA; Feillet F; White FJ; Vidailhet M; Macdonald A; Grimsley A; Maurin N; de Baulny HO; Rutherford PJ Eur J Clin Nutr; 2006 Jul; 60(7):915-20. PubMed ID: 16523206 [TBL] [Abstract][Full Text] [Related]
11. Tetrahydrobiopterin responsiveness in patients with phenylketonuria. Pérez-Dueñas B; Vilaseca MA; Mas A; Lambruschini N; Artuch R; Gómez L; Pineda J; Gutiérrez A; Mila M; Campistol J Clin Biochem; 2004 Dec; 37(12):1083-90. PubMed ID: 15589814 [TBL] [Abstract][Full Text] [Related]
12. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria. Trefz FK; Blau N Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666 [TBL] [Abstract][Full Text] [Related]
13. Does dietary DHA improve neural function in children? Observations in phenylketonuria. Koletzko B; Beblo S; Demmelmair H; Müller-Felber W; Hanebutt FL Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):159-64. PubMed ID: 19615874 [TBL] [Abstract][Full Text] [Related]
14. [Neurological, neuropsychological, and ophthalmological evolution after one year of docosahexaenoic acid supplementation in phenylketonuric patients]. Gutiérrez-Mata AP; Vilaseca MA; Capdevila-Cirera A; Vidal-Oller M; Alonso-Colmenero I; Colomé R; López-Sala A; Lambruschini-Ferri N; Gutiérrez A; Gassió R; Artuch R; Campistol J Rev Neurol; 2012 Aug; 55(4):200-6. PubMed ID: 22829083 [TBL] [Abstract][Full Text] [Related]
20. Supplementation with a powdered blend of PUFAs normalizes DHA and AA levels in patients with PKU. Jans JJ; de Sain-van der Velden MG; van Hasselt PM; van den Hurk DT; Vaz FM; Visser G; Verhoeven-Duif NM Mol Genet Metab; 2013 Jun; 109(2):121-4. PubMed ID: 23562298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]